1,2-dipalmitoylphosphatidylcholine has been researched along with citric acid, anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chung, KF; Dunlop, IE; Gow, A; Herpoldt, KL; Kyo, Y; Leo, BF; McPhail, DS; Porter, AE; Ryan, MP; Schwander, S; Shaffer, MS; Terrill, NJ; Tetley, TD; Zhang, J | 1 |
| Ikeda, A; Kadota, T; Sugikawa, K; Yasuhara, K | 1 |
| Asai, T; Fukuta, T; Honda, M; Namba, M; Oku, N; Yamamoto, H; Yanagida, M; Yanagida, Y | 1 |
3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and citric acid, anhydrous
| Article | Year |
|---|---|
The stability of silver nanoparticles in a model of pulmonary surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Citric Acid; Hydrogen-Ion Concentration; Metal Nanoparticles; Microscopy, Electron, Transmission; Pulmonary Surfactants; Silver | 2013 |
Anisotropic Self-Assembly of Citrate-Coated Gold Nanoparticles on Fluidic Liposomes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Citric Acid; Gold; Liposomes; Metal Nanoparticles; Microscopy, Electron, Transmission; Spectrophotometry, Ultraviolet | 2016 |
Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1,2-Dipalmitoylphosphatidylcholine; Ammonium Sulfate; Animals; Brain; Citric Acid; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Liposomes; Male; Phosphatidylcholines; Quaternary Ammonium Compounds; Rats, Wistar; Reperfusion Injury; Treatment Outcome | 2020 |